Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

Clinical trial NCT06383819 · COMPLETED

Trial details

NCT number: NCT06383819
Sponsor: NPO Petrovax
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Post-Acute COVID-19 Syndrome Lung Disease With Polymyositis Fibrosis Lung Diseases, Interstitial Lung; Disease, Interstitial, With Fibrosis

Start date: 2022-04-08
Primary completion: 2023-12-31
Enrollment: 392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.